Ngā hua rapu - Giovanni Addolorato

Whakamahine hua
  1. 1
    BACLOFEN EFFICACY IN REDUCING ALCOHOL CRAVING AND INTAKE: A PRELIMINARY DOUBLE-BLIND RANDOMIZED CONTROLLED STUDY

    BACLOFEN EFFICACY IN REDUCING ALCOHOL CRAVING AND INTAKE: A PRELIMINARY DOUBLE-BLIND RANDOMIZED CONTROLLED STUDY mā Giovanni Addolorato

    I whakaputaina 2002
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Treatment of alcohol use disorders in patients with alcoholic liver disease

    Treatment of alcohol use disorders in patients with alcoholic liver disease mā Giovanni Addolorato, Antonio Mirijello, Pablo Barrio, Antoni Gual

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Alcohol-Associated Liver Disease: Integrated Management With Alcohol Use Disorder

    Alcohol-Associated Liver Disease: Integrated Management With Alcohol Use Disorder mā Juan Pablo Arab, Giovanni Addolorato, Philippe Mathurin, Mark Thursz

    I whakaputaina 2023
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Baclofen: a new drug for the treatment of alcohol dependence

    Baclofen: a new drug for the treatment of alcohol dependence mā Giovanni Addolorato, Lorenzo Leggio, Roberta Agabio, Giancarlo Colombo, Antonio Gasbarrini

    I whakaputaina 2006
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Management of Alcohol Dependence in Patients with Liver Disease

    Management of Alcohol Dependence in Patients with Liver Disease mā Giovanni Addolorato, Antonio Mirijello, Lorenzo Leggio, Anna Ferrulli, Raffaele Landolfi

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    The therapeutic potential of gamma-hydroxybutyric acid for alcohol dependence: balancing the risks and benefits. A focus on clinical data

    The therapeutic potential of gamma-hydroxybutyric acid for alcohol dependence: balancing the risks and benefits. A focus on clinical data mā Giovanni Addolorato, Lorenzo Leggio, Anna Ferrulli, Fabio Caputo, Antonio Gasbarrini

    I whakaputaina 2009
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Novel Therapeutic Strategies for Alcohol and Drug Addiction: Focus on GABA, Ion Channels and Transcranial Magnetic Stimulation

    Novel Therapeutic Strategies for Alcohol and Drug Addiction: Focus on GABA, Ion Channels and Transcranial Magnetic Stimulation mā Giovanni Addolorato, Lorenzo Leggio, F. Woodward Hopf, Marco Diana, Antonello Bonci

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Alcohol use disorders in the elderly: A brief overview from epidemiology to treatment options

    Alcohol use disorders in the elderly: A brief overview from epidemiology to treatment options mā Fabio Caputo, Teo Vignoli, Lorenzo Leggio, Giovanni Addolorato, Giorgio Zoli, Mauro Bernardi

    I whakaputaina 2012
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Baclofen for the Treatment of Alcohol Dependence and Possible Role of Comorbid Anxiety

    Baclofen for the Treatment of Alcohol Dependence and Possible Role of Comorbid Anxiety mā Kirsten C. Morley, Andrew Baillie, S. Leung, Giovanni Addolorato, Lorenzo Leggio, P.S. Haber

    I whakaputaina 2014
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Review article: alcohol and gut microbiota ‐ the possible role of gut microbiota modulation in the treatment of alcoholic liver disease

    Review article: alcohol and gut microbiota ‐ the possible role of gut microbiota modulation in the treatment of alcoholic liver disease mā Gabriele Vassallo, Antonio Mirijello, Anna Ferrulli, Massimo Antonelli, Raffaele Landolfi, Antonio Gasbarrini, Giovanni Addolorato

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    A Prospective Pharmacogenetic Phase 3 Clinical Trial of Low-Dose Ondansetron (A 5-HT3 Antagonist) to Treat Heavy and Very Heavy Drinkers With Alcohol Use Disorder

    A Prospective Pharmacogenetic Phase 3 Clinical Trial of Low-Dose Ondansetron (A 5-HT3 Antagonist) to Treat Heavy and Very Heavy Drinkers With Alcohol Use Disorder mā Bankole A. Johnson, Hannu Alho, Giovanni Addolorato, Otto Lesch, Jack Reich, Lei Liu, Vinzant Schuyler

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Pré-impressão
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Baclofen promotes alcohol abstinence in alcohol dependent cirrhotic patients with hepatitis C virus (HCV) infection

    Baclofen promotes alcohol abstinence in alcohol dependent cirrhotic patients with hepatitis C virus (HCV) infection mā Lorenzo Leggio, Anna Ferrulli, Antonella Zambon, Fabio Caputo, George A. Kenna, R.M. Swift, Giovanni Addolorato

    I whakaputaina 2011
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    AN OPEN MULTICENTRIC STUDY EVALUATING 4-HYDROXYBUTYRIC ACID SODIUM SALT IN THE MEDIUM-TERM TREATMENT OF 179 ALCOHOL DEPENDENT SUBJECTS

    AN OPEN MULTICENTRIC STUDY EVALUATING 4-HYDROXYBUTYRIC ACID SODIUM SALT IN THE MEDIUM-TERM TREATMENT OF 179 ALCOHOL DEPENDENT SUBJECTS mā Giovanni Addolorato, E Castelli, G.F. Stefanini, G.A. Casella, Fabio Caputo, L. Marsigli, Mauro Bernardi, G. GASBARRIN

    I whakaputaina 1996
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Schizophrenic symptoms and SPECT abnormalities in a coeliac patient: regression after a gluten‐free diet

    Schizophrenic symptoms and SPECT abnormalities in a coeliac patient: regression after a gluten‐free diet mā A. De Santis, Giovanni Addolorato, Alessandra Romito, Salvatore Caputo, Alessandro Giordano, G Gambassi, C. Taranto, Raffaele Manna, Antonio Gasbarrini

    I whakaputaina 1997
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Identification and Management of Alcohol Withdrawal Syndrome

    Identification and Management of Alcohol Withdrawal Syndrome mā Antonio Mirijello, Cristina D’Angelo, Anna Ferrulli, Gabriele Vassallo, Massimo Antonelli, Fabio Caputo, Lorenzo Leggio, Antonio Gasbarrini, Giovanni Addolorato

    I whakaputaina 2015
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Baclofen in the Treatment of Alcohol Withdrawal Syndrome: A Comparative Study vs Diazepam

    Baclofen in the Treatment of Alcohol Withdrawal Syndrome: A Comparative Study vs Diazepam mā Giovanni Addolorato, Lorenzo Leggio, Ludovico Abenavoli, Roberta Agabio, Fabio Caputo, Esmeralda Capristo, Giancarlo Colombo, Gian Luigi Gessa, Antonio Gasbarrini

    I whakaputaina 2006
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    A Prospective Precision Medicine Phase 3 Clinical Trial of Low-dose Ondansetron (a 5-ht3 Antagonist) to Treat Heavy and Very Heavy Drinkers With Alcohol Use Disorder

    A Prospective Precision Medicine Phase 3 Clinical Trial of Low-dose Ondansetron (a 5-ht3 Antagonist) to Treat Heavy and Very Heavy Drinkers With Alcohol Use Disorder mā Bankole A. Johnson, Hannu Alho, Giovanni Addolorato, Otto Lesch, Jonathan Chick, Lei Liu, Jack Reich, Vinzant Schuyler, Zachary A. Rodd

    I whakaputaina 2023
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Pré-impressão
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    A Phase 3 Randomized Precision Medicine Clinical Trial Using Low-Dose Ondansetron (a 5-HT3 Antagonist) to Treat Alcohol Use Disorder

    A Phase 3 Randomized Precision Medicine Clinical Trial Using Low-Dose Ondansetron (a 5-HT3 Antagonist) to Treat Alcohol Use Disorder mā Bankole A. Johnson, Hannu Alho, Giovanni Addolorato, Otto Lesch, Jonathan Chick, Lei Liu, Jack Reich, Vinzant Schuyler, Zachary A. Rodd

    I whakaputaina 2023
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Pré-impressão
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Assessing and Treating Alcohol Relapse Risk in Liver Transplantation Candidates

    Assessing and Treating Alcohol Relapse Risk in Liver Transplantation Candidates mā Geert Dom, Marcin Wojnar, Cleo L. Crunelle, Natasha Thon, Julio Bobes, Ulrich W. Preuss, Giovanni Addolorato, Helmut K. Seitz, F. Wurst

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Liver Transplantation in Alcoholic Patients: Impact of an Alcohol Addiction Unit Within a Liver Transplant Center

    Liver Transplantation in Alcoholic Patients: Impact of an Alcohol Addiction Unit Within a Liver Transplant Center mā Giovanni Addolorato, Antonio Mirijello, Lorenzo Leggio, Anna Ferrulli, Cristina D’Angelo, Gabriele Vassallo, Anthony Cossari, Antonio Gasbarrini, Raffaele Landolfi, S. Agnes, Antonio Gasbarrini

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: